Functioning and health-related quality of life in Chinese patients with systemic sclerosis: A case-control study

Clinical Rheumatology

Volumn 33, Issue 5, 2014, Pages 659-666

  Chan, P T ^a   Mok, C C ^a   Chan, K L ^a   Ho, L Y ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Disability; Functioning; HAQ DI; Quality of life; Scleroderma; SF36; Systemic sclerosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; ILOPROST; METHOTREXATE; PHOSPHODIESTERASE V INHIBITOR; PREDNISOLONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEART INJURY; HUMAN; JOINT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SKIN; SOCIAL INTERACTION; SYSTEMIC SCLEROSIS; TENDON; CHINA; ETHNOLOGY; HEALTH SURVEY; PSYCHOLOGY; QUESTIONNAIRE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; CHINA; FEMALE; HEALTH SURVEYS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902381557     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2525-2     Document Type: Article

References (34)

1. Medsger TA Jr (2003) Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 29:255-273
2. Schouffoer AA, Schoones JW, Terwee CB, Vliet Vlieland TP (2012) Work status and its determinants among patients with systemic sclerosis: a systematic review. Rheumatology (Oxford) 51:1304-1314
3. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M et al (2009) Canadian Scleroderma Research Group. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 36:768-772
4. Johnson SR, Glaman DD, Schentag CT, Lee P (2006) Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 33:1117-1122 (Pubitemid 43825462)
5. Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O et al (2006) Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford) 45:1298-1302 (Pubitemid 44542074)
6. Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A et al (2004) Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. Arthritis Rheum 51:475-481 (Pubitemid 38725150)
7. Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I et al (2005) Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24:48-54 (Pubitemid 40214800)
8. Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M et al (2008) Canadian Scleroderma Research Group Investigators. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59:279-284 (Pubitemid 351272966)
9. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M et al (2009) Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112-1120
10. Gliddon AE, Dore CJ (2006) Maddison PJ; the Quins Trial Study Group. Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. Arthritis Rheum 55:473-479 (Pubitemid 43887034)
11. Wang J, Assassi S, Guo G, Tu W, Wu W, Yang L et al (2013) Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 32:617-621
12. Ling ALH, Teng GG, Law WG, NG SC, Santosa A, Chan G et al (2013) Disease characteristics of the Singapore systemic sclerosis cohort. Proceedings of Singapore Healthcare 22:9-14
13. Mok CC, Chan PT, Chan KL, Ma KM (2013) Prevalence and risk factors of low bonemineral density in Chinese patients with systemic sclerosis: a case-control study. Rheumatology (Oxford) 52:296-303
14. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong China. Arthritis Rheum 63:1182-1189
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-90
16. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573-1576 (Pubitemid 32660630)
17. Valentini G, D'Angelo S, Della Rossa A, Bencivelli W, Bombardieri S (2003) European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 62:904-905 (Pubitemid 37026506)
18. Medsger TAJR, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis. Development and testing. J Rheumatol 26:2159-2162
19. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145 (Pubitemid 10164318)
20. Ware JE Jr, Sherbourne CD (1992) The MOS, 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
21. Lam CLK, Lauder IJ, Lam TP, Gandek B (1999) Population based norming of the Chinese (HK) version of the SF-36 health survey. Hong Kong Practitioner 21:460-470 (Pubitemid 29505922)
22. Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J et al (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and Medical Outcomes Study 36-item Short Form health survey. Arthritis Rheum 57:94-102
23. Mayes MD (2003) Scleroderma epidemiology. Rheum Dis Clin North Am 29:239-254
24. Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM et al (2003) Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 22:130-139 (Pubitemid 36307560)
25. Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 50:762-767
26. Mouthon L, Mestre-Stanislas C, Bérezné A, Rannou F, Guilpain P, Revel M et al (2010) Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69:214-217
27. Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:1971-1978
28. Ngian GS, Sahhar J, Wicks IP, Van Doornum S (2011) Cardiovascular disease in systemic sclerosis-an emerging association? Arthritis Res Ther 13:237
29. Keefe FJ, Caldwell DS. Cognitive behavioral interventions. In: Wegner ST, Belza BL, Gall EP, editors. Clinical care in the rheumatic diseases. Atlanta: American College of Rheumatology 1996:59-63
30. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM (1998) A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 49:59-72 (Pubitemid 28139098)
31. Butters JW, Cash TF (1987) Cognitive-behavioral treatment of women's body-image dissatisfaction. J Consult Clin Psychol 55:889-897
32. Cash TF. The treatment of body image disturbances. In: Thompson JK, editor. Body image, eating disorders, and obesity: an integrative guide to assessment and treatment. Washington, D.C.: American Psychological Association 1996:83-108.
33. Antonioli CM, Bua G, Frigè A, Prandini K, Radici S, Scarsi M et al (2009) An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol 28:159-165
34. Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J et al (2011) Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 63:909-917